https://patholines.org/index.php?title=Irradiated_blood&feed=atom&action=historyIrradiated blood - Revision history2024-03-29T10:53:53ZRevision history for this page on the wikiMediaWiki 1.33.0https://patholines.org/index.php?title=Irradiated_blood&diff=2697&oldid=prevMikael Häggström: Started2020-10-30T23:49:51Z<p>Started</p>
<p><b>New page</b></p><div>{{Top<br />
|author1=[[User:Mikael Häggström|Mikael Häggström]]<br />
|author2=<br />
}}<br />
Cellular blood components for the following patients/situations should be irradiated to reduce the risk of transfusion associated graft-versus-host disease:<ref>{{cite web|url=http://psons.org/wp-content/uploads/2015/03/21a-PSBC-Blood-Components-Special-Attributes-Indications-2015.pdf|title=Puget Sound Blood Center - Indications for Special Attributes - Blood Components to Minimize CMV Transmission|accessdate=2020-10-30}}</ref><br />
*Hematopoietic stem cell (HSC) transplant recipients<br />
*HSC transplant candidates under some circumstances<br />
*HSC donors if allogeneic transfusion must be given prior to completing the harvest<br />
*Congenital T-cell immune deficiency<br />
*Intrauterine or neonatal exchange transfusion<br />
*Transfusion from family members or HLA-selected donors<br />
*Patients who have had fludarabine chemotherapy<br />
*Hodgkin’s disease<br />
*Leukemia<br />
*Lymphoproliferative disorders<br />
*Granulocyte transfusion<br />
*Neonates<br />
*Aggressive chemotherapy, radiotherapy or T-cell immunosuppression<br />
{{Bottom}}</div>Mikael Häggström